Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bath & Body Works Inc (BBWI) vs Canopy Growth Corp (CGC) Price & Performance

Bath & Body Works IncTrade
Canopy Growth CorpTrade

Price performance (Past 24H)

Key statistics

Bath & Body Works Inc vs Canopy Growth Corp — how do they compare? Bath & Body Works Inc trades at $18.4 (market cap $3.81B), while Canopy Growth Corp trades at $1.01 (market cap $421.10M). The key difference: Bath & Body Works Inc is far larger — about 9× Canopy Growth Corp's market cap, and Bath & Body Works Inc pays a 4.24% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.

BBWICGC
Market Cap
$3.81B$421.10M
Sector
Consumer CyclicalHealth
52-Week High
$31.87$1.92
52-Week Low
$14.85$0.86
Enterprise Value
$7.70B$378.55M
Dividend Yield
4.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bath & Body Works Inc

BBWI trades at $19.32, down 5.11% over 24 hours, with a bearish technical signal and key support at $19. The stock shows attractive valuation metrics, including a P/E of 5.36 and P/S of 0.54, with a net income margin of 10.03% for 2025. Recent developments include expansion into Brazil and a partnership with Ulta Beauty, while Q2 2026 earnings are anticipated on August 26, 2026.

The outlook presents a value opportunity given low valuations and strategic growth initiatives, but risks include declining revenue trends, high debt levels, and negative shareholder equity. Analyst consensus is mixed with a $22.11 price target, suggesting potential upside if turnaround efforts succeed amidst competitive and execution challenges.

Canopy Growth Corp

CGC trades at $0.95, down 1.86% in the last session, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year, beating estimates, but continues to post net losses. Recent news highlights expansion in European cannabis markets and cost-cutting efforts, while the stock remains volatile amid regulatory uncertainty.

Outlook is cautious due to persistent losses and high debt, though improving cash flow and revenue growth offer potential upside. Key risks include regulatory delays in U.S. cannabis rescheduling and competitive pressures. Investors should weigh the speculative nature against any positive regulatory catalysts.

Returns comparison

Trailing returns across standard periods

About Bath & Body Works Inc

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.

Read more on BBWI

About Canopy Growth Corp

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more on CGC